These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 19076342

  • 1. Toll-like receptors in autoimmunity.
    Fischer M, Ehlers M.
    Ann N Y Acad Sci; 2008 Nov; 1143():21-34. PubMed ID: 19076342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT.
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nucleic acid recognition receptors in autoimmunity.
    Krug A.
    Handb Exp Pharmacol; 2008 Nov; (183):129-51. PubMed ID: 18071658
    [Abstract] [Full Text] [Related]

  • 8. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM, Vollmer J.
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [Abstract] [Full Text] [Related]

  • 9. The role of innate immunity in autoimmune tissue injury.
    Allam R, Anders HJ.
    Curr Opin Rheumatol; 2008 Sep; 20(5):538-44. PubMed ID: 18698174
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential tissue targeting of autoimmunity manifestations by autoantigen-associated Y RNAs.
    Greidinger EL, Zang Y, Martinez L, Jaimes K, Nassiri M, Bejarano P, Barber GN, Hoffman RW.
    Arthritis Rheum; 2007 May; 56(5):1589-97. PubMed ID: 17469141
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of toll-like receptors in chronic inflammation.
    Drexler SK, Foxwell BM.
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [Abstract] [Full Text] [Related]

  • 16. The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review.
    Jiménez-Dalmaroni MJ, Gerswhin ME, Adamopoulos IE.
    Autoimmun Rev; 2016 Jan; 15(1):1-8. PubMed ID: 26299984
    [Abstract] [Full Text] [Related]

  • 17. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules.
    Foell D, Wittkowski H, Vogl T, Roth J.
    J Leukoc Biol; 2007 Jan; 81(1):28-37. PubMed ID: 16943388
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptors and diabetes.
    Wong FS, Wen L.
    Ann N Y Acad Sci; 2008 Dec; 1150():123-32. PubMed ID: 19120280
    [Abstract] [Full Text] [Related]

  • 19. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S, Morva A, Youinou P, Jamin C.
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [Abstract] [Full Text] [Related]

  • 20. Complement and Toll-like receptors: key regulators of adaptive immune responses.
    Hawlisch H, Köhl J.
    Mol Immunol; 2006 Jan; 43(1-2):13-21. PubMed ID: 16019071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.